New Strategies to Combat Human Fungal Infections

Overview

Journal J Fungi (Basel)

Date 2024 Dec 27

PMID 39728376

Authors

Andre Luis Souza Dos Santos

Marta Helena Branquinha

Affiliations

Soon will be listed here.

Abstract

Over the past few decades, numerous reports have highlighted the significant rise in fungal infections worldwide, contributing to considerable morbidity, mortality, and escalating healthcare costs [...].

References

Denning D . Global incidence and mortality of severe fungal disease. Lancet Infect Dis. 2024; 24(7):e428-e438. DOI: 10.1016/S1473-3099(23)00692-8. View

Akinosoglou K, Rigopoulos E, Papageorgiou D, Schinas G, Polyzou E, Dimopoulou E . Amphotericin B in the Era of New Antifungals: Where Will It Stand?. J Fungi (Basel). 2024; 10(4). PMC: 11051097. DOI: 10.3390/jof10040278. View

Rayens E, Rayens M, Norris K . Demographic and Socioeconomic Factors Associated with Fungal Infection Risk, United States, 2019. Emerg Infect Dis. 2022; 28(10). PMC: 9514344. DOI: 10.3201/eid2810.220391. View

Sousa I, Vieira T, Menna-Barreto R, Guimaraes A, McCarron P, McCann M . Silver(I) 1,10-Phenanthroline Complexes Are Active against Viability and Negatively Modulate Its Potential Virulence Attributes. J Fungi (Basel). 2023; 9(3). PMC: 10057124. DOI: 10.3390/jof9030356. View

Puumala E, Fallah S, Robbins N, Cowen L . Advancements and challenges in antifungal therapeutic development. Clin Microbiol Rev. 2024; 37(1):e0014223. PMC: 10938895. DOI: 10.1128/cmr.00142-23. View

Brilhante R, Costa A, Mesquita J, Dos Santos Araujo G, Freire R, Nunes J . Antifungal Activity of Chitosan against in Planktonic and Biofilm Forms: A Therapeutic Strategy in the Future?. J Fungi (Basel). 2023; 9(12). PMC: 10744476. DOI: 10.3390/jof9121201. View

Fusco A, Perfetto B, Savio V, Chiaromonte A, Torelli G, Donnarumma G . Regulatory Ability of on Human Skin Health by Counteracting In Vitro Effects. J Fungi (Basel). 2023; 9(12). PMC: 10744525. DOI: 10.3390/jof9121153. View

Andrade I, Correa-Junior D, Alves V, Figueiredo-Carvalho M, Santos M, Almeida M . Cyclosporine Affects the Main Virulence Factors of In Vitro. J Fungi (Basel). 2023; 9(4). PMC: 10140927. DOI: 10.3390/jof9040487. View

Caston-Osorio J, Rivero A, Torre-Cisneros J . Epidemiology of invasive fungal infection. Int J Antimicrob Agents. 2008; 32 Suppl 2:S103-9. DOI: 10.1016/S0924-8579(08)70009-8. View

10.

Vahedi-Shahandashti R, Stubenbock M, Lass-Florl C . The Influence of Medium Composition on EUCAST and Etest Antifungal Susceptibility Testing. J Fungi (Basel). 2023; 9(10). PMC: 10608067. DOI: 10.3390/jof9100973. View

11.

Suleyman G, Alangaden G . Nosocomial Fungal Infections: Epidemiology, Infection Control, and Prevention. Infect Dis Clin North Am. 2021; 35(4):1027-1053. DOI: 10.1016/j.idc.2021.08.002. View

12.

Jose P, Alvarez-Lerma F, Maseda E, Olaechea P, Peman J, Soriano C . Invasive fungal infection in crtically ill patients: hurdles and next challenges. J Chemother. 2019; 31(2):64-73. DOI: 10.1080/1120009X.2018.1557799. View

13.

Xisto M, Rollin-Pinheiro R, Castro-Almeida Y, Santos-Freitas G, Rochetti V, Borba-Santos L . Promising Antifungal Molecules against Mucormycosis Agents Identified from Pandemic Response Box: In Vitro and In Silico Analyses. J Fungi (Basel). 2023; 9(2). PMC: 9959553. DOI: 10.3390/jof9020187. View

14.

Singh N, Kumari V, Agrawal K, Kulshreshtha M . Molecular Pathway, Epidemiological Data and Treatment Strategies of Fungal Infection (Mycoses): A Comprehensive Review. Cent Nerv Syst Agents Med Chem. 2024; 24(1):68-81. DOI: 10.2174/0118715249274215231205062701. View

15.

Giannella M, Lanternier F, Delliere S, Groll A, Mueller N, Alastruey-Izquierdo A . Invasive fungal disease in the immunocompromised host: changing epidemiology, new antifungal therapies, and management challenges. Clin Microbiol Infect. 2024; 31(1):29-36. DOI: 10.1016/j.cmi.2024.08.006. View

16.

Leng X, Zhou H, Xu Z, Xu F . Oral Isavuconazole Combined with Nebulized Inhalation and Bronchoscopic Administration of Amphotericin B for the Treatment of Pulmonary Mucormycosis: A Case Report and Literature Review. J Fungi (Basel). 2024; 10(6). PMC: 11204425. DOI: 10.3390/jof10060388. View

17.

Ampel N . Emerging disease issues and fungal pathogens associated with HIV infection. Emerg Infect Dis. 1996; 2(2):109-16. PMC: 2639832. DOI: 10.3201/eid0202.960205. View

18.

Fisher M, Alastruey-Izquierdo A, Berman J, Bicanic T, Bignell E, Bowyer P . Tackling the emerging threat of antifungal resistance to human health. Nat Rev Microbiol. 2022; 20(9):557-571. PMC: 8962932. DOI: 10.1038/s41579-022-00720-1. View